Development of Quidelines for The Prevention of Adverse Events Due to The Vaccination Against Coronavirus Infection in 2019 in Khon Kaen Province

Abstract

The objective of this research is to study the adverse events following the COVID vaccine (AEFI) and develop a monitoring model for Khon Kaen's health service network. The implementation uses system theory as a framework to manage Chemis' continuous development cycle as a tool. The target group is the Quality Assurance and Monitoring team. After receiving the vaccine, 40 people were selected specifically. Tools used 1. Survey of adverse events after receiving the COVID vaccine 2. Questionnaire for the Implementation of Quality Insurance Analysis with Descriptive Statistics, Period January to September 2025, Results of Study 1. Approximately 1,913,920 COVID-19 recipients reported non-serious AEFI adverse events of 0.34, serious AEFI of 0.003, and death of 0.002 with serious AEFI in the over-60 age group. 45 (45.92) As a result, risk groups were identified for the monitoring and development of emergency patient transmission systems. The most common cause of death is the brain and nervous system, followed by the cardiovascular system. 2. The AEFI surveillance system that has been implemented is: 1) the transmission system for newborn patients. There is serious AEFI between the hospital and the area. 2) the development of primary service personnel in the initial assessment of AEFI, and 3) a proactive monitoring system linking the customer database.4) the development of a primary monitoring community and reporting capabilities. Cooperation from all service sectors and communities in the development of the AEFI monitoring system will reduce adverse events.